Combined central retinal artery and vein occlusion with ischemic optic neuropathy after COVID-19 vaccination

S Lee, KK Sankhala, S Bose… - … Medical Case Reports …, 2022 - Taylor & Francis
S Lee, KK Sankhala, S Bose, RP Gallemore
International Medical Case Reports Journal, 2022Taylor & Francis
Purpose To report a case of combined central retinal vein and artery occlusion that evolved
into ischemic optic neuropathy following the Pfizer COVID-19 vaccination. Methods Patient
was followed with optical coherence tomography (OCT), fluorescein angiography, and
Humphrey visual field. Results Patient was able to recover vision from count fingers to 20/30
on a combination of aflibercept, steroidal and non-steroidal anti-inflammatories, a diuretic
(acetazolamide), antiplatelet agents (aspirin and pentoxifylline), and an anticoagulant …
Purpose
To report a case of combined central retinal vein and artery occlusion that evolved into ischemic optic neuropathy following the Pfizer COVID-19 vaccination.
Methods
Patient was followed with optical coherence tomography (OCT), fluorescein angiography, and Humphrey visual field.
Results
Patient was able to recover vision from count fingers to 20/30 on a combination of aflibercept, steroidal and non-steroidal anti-inflammatories, a diuretic (acetazolamide), antiplatelet agents (aspirin and pentoxifylline), and an anticoagulant (apixaban).
Conclusion
COVID-19 vaccination may be associated with a myriad of sight-threatening ocular thrombotic conditions, which may respond to a combination of anti-inflammatory and anticoagulant therapies.
Taylor & Francis Online